YD Bio Limited (NASDAQ:YDES – Get Free Report) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 25,094 shares, a growth of 124.7% from the June 30th total of 11,169 shares. Based on an average daily volume of 621,113 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.
Institutional Inflows and Outflows
An institutional investor recently raised its stake in YD Bio stock. Geode Capital Management LLC grew its holdings in shares of YD Bio Limited (NASDAQ:YDES – Free Report) by 10.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 58,363 shares of the biotechnology company’s stock after acquiring an additional 5,292 shares during the quarter. Geode Capital Management LLC owned 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.
YD Bio Trading Down 1.3%
YDES opened at $2.27 on Thursday. The stock has a 50-day moving average price of $2.74 and a 200-day moving average price of $6.18. YD Bio has a 12-month low of $1.70 and a 12-month high of $25.00.
About YD Bio
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
Featured Stories
- Five stocks we like better than YD Bio
- Palantir’s Earnings Setup Puts Its AI Growth Story Back on Trial Again
- Mining For Megawatts: AMD’s Billion-Dollar Grid Grab
- Circle’s IBM Patent Deal Could Redraw the Stablecoin Infrastructure Race
- Survey Reveals: 62% of US Households Are Cutting Back on Protein as Grocery Prices Rise [2026]
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
